Advertisements

Ténordate

Quick links to important sections

Ténordate

Advertisements
Advertisements

Method of action: Antianginal, Antihypertensive

Treatment option: Hypertension, Angina Pectoris

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Ténordate

Ténordate is a prescription-only, synthetic fixed-dose combination medicine administered as an oral tablet, designed for the sustained management of cardiovascular conditions. It is classified as an antihypertensive agent because its formulation provides the combined, synergistic effects of two established pharmacological classes.

Property Description
Active ingredient Atenolol, Nifedipine
Form Oral Tablet
Pharmacological class Beta-Blocker and Calcium Channel Blocker Combination
Common use Hypertension and Angina Pectoris Management
Origin Synthetic

What Type of Medicine is Ténordate?

Ténordate is a fixed-dose combination product containing the active ingredients Atenolol and Nifedipine, delivering the therapeutic actions of both a Beta-Blocker and a Calcium Channel Blocker in a single unit. This structure is a specific strategy in pharmacology to address conditions like hypertension through multiple, distinct pathways simultaneously. The medicine is primarily prescribed when a patient requires the simultaneous effects of both a substance that modulates cardiac activity and one that promotes the widening of peripheral blood vessels.


What is the Composition of Ténordate?

The composition features two active substances: Atenolol, a beta-1–selective adrenergic antagonist, and Nifedipine, a dihydropyridine Calcium ion antagonist. This pairing is distinct because it targets two key physiological control points: the heart's rate and the blood vessels' resistance. These ingredients are formulated into an oral tablet using pharmaceutical excipients that form the solid dosage matrix, facilitating its convenient oral route of administration. This fixed combination harnesses the complementary effects of cardiac moderation and peripheral vascular resistance reduction.


What is the General Purpose of Ténordate?

The general purpose of Ténordate is to assist in the sustained control of elevated blood pressure, or hypertension, and to manage the symptoms associated with angina pectoris (chest pain). By simultaneously decreasing the heart's overall workload and allowing for enhanced blood flow through relaxed systemic arteries, the medicine aims to stabilize cardiovascular function. A typical use scenario involves long-term maintenance therapy for adult patients whose blood pressure or angina symptoms are not adequately controlled by either of the components used alone.

Advertisements

What side effects are possible with Ténordate?

Possible Side Effects and Safety Information

The safety profile for Ténordate, a fixed-dose combination of Atenolol and Nifedipine, is characterized by adverse reactions documented in official regulatory labeling. These effects are classified by frequency and grouped into System-Organ Classes (SOCs), primarily affecting the cardiovascular and nervous systems.

Officially documented adverse reactions are categorized as follows:

  • Common Reactions (may affect up to 1 in 10 people): Fatigue, tiredness, headache, dizziness, slow heart rate (bradycardia), localized swelling (edema), flushing, constipation, and nausea.
  • Uncommon Reactions (may affect up to 1 in 100 people): Depression, insomnia, vertigo, dry mouth, and numbness or tingling (paresthesia).

Serious adverse reactions explicitly cited in regulatory documents include Overt Cardiac Failure, Severe Hypotension (significant drop in blood pressure), and Heart Block greater than the first degree. The label also notes the risk of exacerbated angina or myocardial infarction associated with the abrupt cessation of the beta-blocker component (Atenolol) in patients with coronary artery disease.

Safety constraints define the boundaries for use. The medicine is contraindicated in specific conditions, including Sinus Bradycardia, Cardiogenic Shock, and pre-existing Overt Cardiac Failure. Furthermore, use in older adults and patients with renal impairment requires particular consideration due to altered drug elimination patterns, which may necessitate dosage adjustment.

Advertisements

Overdose and Emergency Response

The official regulatory profile for a Ténordate overdose defines a severe, potentially life-threatening event requiring immediate medical intervention. Overdose manifestations are primarily cardiovascular, reflecting the combined effects of the beta-blocker (Atenolol) and calcium channel blocker (Nifedipine) components.

Documented signs of overdose include profound bradycardia (excessively slow heart rate), severe hypotension (critically low blood pressure), and episodes of syncope or extreme systemic weakness. Other manifestations include shortness of breath and physical signs of fluid retention, such as unexplained weight gain or swelling of the extremities.

The most serious outcomes documented include progression to Heart Block, worsening Heart Failure, and Cardiogenic Shock. Central nervous system depression, including Coma or Respiratory Depression, is also listed.

Regulatory guidance explicitly mandates that individuals who suspect an overdose must seek immediate medical attention and contact emergency services. Given the severity, close hospital monitoring is required. Official management is constrained by the fact that no specific antidote is known. Therefore, care focuses on procedural measures like symptomatic and supportive treatment, which may involve specific interventions like High-dose insulin therapy and, where appropriate, the use of activated charcoal or gastric lavage. Overdose may be especially severe in patients with Renal Impairment due to reduced clearance of the Atenolol component.

Advertisements

Therapeutic Uses of Ténordate

What Ténordate Treats: Main Uses and Benefits

Ténordate (which often contains the active ingredient atenolol, a beta-blocker) is generally used in therapeutic domains where supportive symptom management is appropriate, primarily applied in addressing conditions involving episodic or fluctuating manifestations of cardiovascular stress.

The medication is commonly used across conditions presenting with acute episodes of high blood pressure (hypertension) and to help with easing the physical discomfort of chest pain related to angina. It is also considered relevant in clinical settings that involve acute or unstable symptom patterns, such as providing support after a heart attack.

The medication plays a role in managing symptom clusters related to heightened physiological activity, which may create noticeable physiological strain. It is used in scenarios marked by temporary physiological imbalance.

“This supportive relief may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.”

Quick Fact: Relevant for Easing Symptoms related to Physical Discomfort

Regulatory References

  1. NIH MedlinePlus Drug Information on Atenolol
Advertisements

Eligibility and Restrictions for Use

Ténordate (testosterone undecanoate) is an androgen replacement therapy indicated only for adult males with specific, documented conditions causing testosterone deficiency, such as primary or hypogonadotropic hypogonadism. Its use is limited to conditions with structural or genetic etiologies, and it is not recommended for treating hypogonadism associated only with aging, which is also known as age-related hypogonadism.

Populations Strictly Prohibited from Use (Contraindications)

  • Women who are pregnant (Testosterone can cause virilization, or fetal harm).
  • Men with known or suspected carcinoma of the breast or prostate.
  • Individuals with a known hypersensitivity to the drug or its ingredients.

Eligibility Restrictions and Special Considerations

  • Age: Safety and efficacy have not been established for males less than 18 years old.
  • Health Conditions: Use is not recommended in men with uncontrolled hypertension. It requires caution in patients with pre-existing cardiac, renal, or hepatic disease due to the risk of edema (swelling), which may lead to or worsen congestive heart failure. These patients should be monitored closely.
Advertisements

What should I know about interactions with other medicines?

The medicinal product Ténordate is a combination drug containing the beta-blocker atenolol and the thiazide-like diuretic chlorthalidone. Its interaction profile is determined by the combined effects and individual properties of these two active components.

Interactions with Concomitant Medicines

Co-administration with other medicines may lead to clinically significant interactions, which are broadly classified based on potential severity. Key interacting substance categories include:

  • Other antihypertensive agents: Combining with other blood pressure-lowering medicines, such as Calcium Channel Blockers (e.g., verapamil, diltiazem), may lead to an exaggerated drop in blood pressure and/or severe bradycardia. This combination is often contraindicated or requires strict monitoring.
  • Antiarrhythmics: The risk of cardiotoxicity, particularly bradycardia (slow heart rate), is increased when combined with certain antiarrhythmic drugs (e.g., amiodarone).
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): These can diminish the antihypertensive effect of both atenolol and chlorthalidone.
  • Digitalis glycosides (e.g., digoxin): This combination increases the risk of digitalis toxicity, as the chlorthalidone component can induce hypokalemia (low potassium).

Other Interaction-Related Notes

The chlorthalidone component requires periodic monitoring of serum electrolytes (such as potassium) to detect and manage potential imbalances, especially when co-administered with drugs that also affect potassium levels (e.g., corticosteroids). Alcohol consumption and certain food components may also have additive effects, potentially increasing the risk of orthostatic hypotension.

Advertisements

Mechanism of Action

The mechanism of Ténordate, a fixed-dose combination of Atenolol and Nifedipine, relies on simultaneously influencing the two major determinants of circulatory dynamics: cardiac output and peripheral resistance. The combined action provides a two-pronged approach to physiological adjustment of these parameters.


Modulation of Cardiac and Renal Sympathetic Signaling

This domain covers Atenolol's action as a selective beta1-adrenergic antagonist. By blocking these receptors, the drug directly reduces the effects of sympathetic stimulation on the heart, reducing both the heart's rate and the force of its contractions. A secondary effect involves suppressing the release of Renin from the kidney, which modulates the hormonal pathway governing blood vessel constriction.


Regulation of Peripheral Vascular Tone

This domain centers on Nifedipine's role as an inhibitor of L-type voltage-gated Calcium channels in arterial smooth muscle. Blocking the influx of Ca^2+ ions prevents muscle contraction, leading to widespread peripheral and coronary vasodilation. This physiological effect directly reduces the resistance that the heart must pump against, which lowers the systemic circulatory load.


Synergistic Hemodynamic Control

The combination creates mechanistic synergy by integrating a cardiac output reducer (Atenolol) with a peripheral resistance reducer (Nifedipine). Atenolol's beta1-blockade mechanistically prevents the reflex tachycardia that Nifedipine's potent vasodilation might otherwise trigger. This coordinated action results in a balanced hemodynamic adjustment.

Advertisements

Dosage and Administration Information

The use of Ténordate, a fixed-dose combination of Atenolol and Nifedipine, involves specific parameters to ensure appropriate administration. The medicine is exclusively for oral administration as a hard capsule and is intended for long-term, continuous management of cardiovascular conditions.

Official Dosing and Frequency

Administration involves a consistent daily pattern, often adjusted based on the specific condition. The standard fixed dose contains 50 mg Atenolol and 20 mg Nifedipine (Sustained Release).

Indication Standard Daily Regimen Maximum Frequency
Hypertension One capsule once daily Twice daily (if needed)
Angina Pectoris One capsule every 12 hours Twice daily

The maximum recommended frequency for this fixed-dose combination, regardless of the condition, is twice daily.

Procedural and Population Constraints

To maintain the intended sustained-release effect, the capsule must be swallowed whole with water and must not be broken, crushed, or chewed. The medicine should not be taken with grapefruit juice due to its potential to affect the body's processing of Nifedipine.

Dosage adjustments are outlined for vulnerable groups. For older patients being treated for hypertension, the dosage generally should not exceed one capsule daily. Additionally, patients with renal or hepatic insufficiency typically require lower dosages to prevent drug accumulation, a principle consistent with the pharmacokinetics of the individual components. The medicine is not recommended for use in the paediatric population.

Advertisements

Recent Clinical Evidence

Ténordate: Recent Clinical Evidence


Evidence for Use in Essential Hypertension

The clinical research for essential high blood pressure relies on Randomized Controlled Trials (RCTs) and meta-analyses that compare the fixed-dose combination against its individual components, Atenolol and Nifedipine, when used alone. Research examined outcomes related to clinical and ambulatory systolic and diastolic blood pressure (BP). Studies show patterns related to differences in blood pressure measurements between the combination and the individual ingredients in the short term, including changes in the stability of BP over 24 hours. A key limitation is that many core comparative trials have limited follow-up durations (often four to six months), meaning long-term outcomes are not fully established.


Evidence for Use in Stable Angina Pectoris

The fixed-dose combination was evaluated in research exploring conditions such as stable angina pectoris. Evidence is primarily derived from short-term Randomized Controlled Trials that observed patient-reported outcomes describing perceived discomfort. The data show patterns related to the monitored frequency of anginal episodes and outcomes related to exercise tolerance and the use of rescue medications. Research highlights that much of the supporting evidence for long-term use is specific to sustained-release or modified-release Nifedipine formulations in combination with a beta-blocker, providing context for its use.


Long-Term Studies and Areas of Uncertainty

Research has explored whether patterns of blood pressure measurements persist over time using observational cohort studies and meta-analyses covering multi-year periods. These larger analyses track long-term cardiovascular event occurrence, such as heart attack and stroke. However, comparative evidence is lacking to definitively contrast this specific fixed-dose product with every other long-term regimen. The fixed-dose structure is a known constraint as it limits the ability to individually adjust the dose of the two active ingredients independently. The results apply only to the populations studied, and data for certain groups, such as children, remains limited.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Ténordate (FAQ)

Q: How quickly can a person expect to feel the effects of Ténordate?

A: The active ingredients in Ténordate, Nifedipine and Atenolol, are absorbed by the body after administration. Official pharmacokinetics data indicates that the components typically reach their highest levels in the blood within 2 to 5 hours after ingestion. This indicates that measurable effects on blood pressure and heart rate may begin within a few hours of administration.


Q: Does Ténordate have a risk of withdrawal symptoms if stopped suddenly?

A: Regulatory documents include a warning regarding the sudden discontinuation of this medicine. Stopping the beta-blocker component, Atenolol, abruptly may potentially lead to a worsening of chest pain (angina) or, in patients with coronary artery disease, an increased risk of a heart attack (myocardial infarction). Official guidance notes that abrupt discontinuation of the medicine is generally discouraged.


Q: Can Ténordate affect a person's mood or cause anxiety?

A: Official product information lists changes in mood as potential side effects. Specifically, regulatory labeling cites depression and insomnia (difficulty sleeping) as uncommon reactions. While anxiety is not explicitly listed, other mood changes and feelings of nervousness may be associated with the individual drug components.


Q: Are there common household items or foods that interact with Ténordate?

A: Yes, regulatory documents state that Ténordate is to be administered without grapefruit juice, as this may significantly increase the level of the Nifedipine component in the blood. Furthermore, alcohol consumption may have additive effects that increase the risk of an excessive drop in blood pressure when standing up (orthostatic hypotension).


Q: Is Ténordate considered safe to use for older adults?

A: Use in older adults requires particular consideration due to potential changes in how the body eliminates the medicine. Regulatory documents state that for older patients being treated for hypertension, the maximum daily amount typically should not be exceeded. These guidelines are in place to address the unique considerations for use in this population.


Q: Is Ténordate likely to interact with common pain relievers like ibuprofen?

A: Official documents describe that other types of medicines may interact with Ténordate. The blood pressure-lowering effect of Ténordate can be diminished by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes common over-the-counter pain relievers.


Q: Can Ténordate affect sleeping patterns?

A: Yes, official regulatory labeling lists potential effects on sleep. Insomnia (difficulty sleeping) is cited as an uncommon adverse reaction associated with this medication.


Q: Is Ténordate a drug that is often prescribed long-term?

A: Yes, according to official dosing and indication sections, Ténordate is intended for the long-term, continuous management of cardiovascular conditions like hypertension and angina. However, official evidence also indicates that the core comparative trials have often had limited follow-up durations.


Q: Can Ténordate be taken by people with kidney problems?

A: Yes, but with specific considerations. Official guidelines note that patients with renal (kidney) or hepatic (liver) insufficiency typically require lower dosages to prevent drug buildup. Use in patients with kidney problems is subject to official caution due to the body’s altered ability to process the drug.


Q: Why are people often told not to stop Ténordate suddenly?

A: Official regulatory warnings note that abrupt discontinuation of Ténordate carries the risk of serious cardiac events. Stopping suddenly may result in a rapid worsening of pre-existing angina or, in certain patients, could trigger a heart attack (myocardial infarction) due to the withdrawal of the Atenolol component.


Q: What is the role of Ténordate in managing heart failure?

A: Ténordate is contraindicated, meaning it should not be used, in patients who have pre-existing serious heart conditions, including Overt Cardiac Failure or Cardiogenic Shock. The medicine is designed for managing hypertension and angina, not for treating these severe forms of heart failure.


Q: Are there any long-term effects associated with Ténordate use?

A: Regulatory information indicates that the supporting evidence for this specific fixed-dose combination includes observational cohort studies that track cardiovascular events over multi-year periods. Official documents also note a key limitation: many core comparative trials have had limited follow-up durations, meaning long-term outcomes are not fully established.


Q: Does Ténordate cause weight gain or weight loss?

A: Regulatory labeling for the components suggests a possible link to changes in weight. Although not listed as a common reaction for the combination product, the nifedipine component is sometimes associated with unusual weight gain or loss, and localized swelling (edema) is a common side effect which may affect weight.


Q: What are the signs that Ténordate might be causing low blood pressure?

A: Because the drug works to lower blood pressure, some people may experience a drop that is too significant (Hypotension). Signs of this excessive drop or a slow heart rate (bradycardia) may include dizziness, lightheadedness, or fainting.


Q: Are there specific symptoms that require immediately contacting a doctor while taking Ténordate?

A: Symptoms like an allergic reaction (e.g., swelling of the face or throat, trouble breathing) are cited in regulatory warnings as requiring prompt attention. This also applies to serious cardiac issues, such as chest pain that is new or getting worse.


Q: Is Ténordate known to interact with herbal supplements?

A: Yes, regulatory information advises caution with certain herbal products. Examples cited for potential effects on how the drug components work include common supplements like St John's Wort, Ginkgo biloba, and Ginseng.


Q: What does it mean if Ténordate is described as 'selective'?

A: The Atenolol component in Ténordate is described as a beta1-selective beta-blocker in its mechanism of action. This means it primarily targets the beta1 receptors found mainly in the heart muscle, aiming to influence cardiac activity while potentially having fewer effects on other body systems.


Q: What happens if a dose of Ténordate is missed?

A: Official instructions state that a double dose should not be taken to compensate for a forgotten one. Specific next steps for taking the medicine depend on the usual dosing frequency (e.g., once-a-day or twice-a-day).


Q: Does Ténordate affect fertility or sexual function?

A: Official labeling for the individual components notes potential effects on sexual function. Side effects may include a decreased sexual ability or desire and can also involve erectile dysfunction.


Q: Are there specific vitamins or minerals that should be avoided while taking Ténordate?

A: Yes. According to regulatory interaction data, taking multivitamins with minerals may decrease the effectiveness of the Atenolol and Nifedipine components. Regulatory information indicates that separating administration times by at least 2 hours may be required to manage this interaction.


Q: Is Ténordate a drug that requires regular blood tests?

A: Yes. Due to the effects of the diuretic component (Chlorthalidone), which can affect the body's salt balance, regular monitoring of serum electrolytes (substances like potassium) may be required.


Q: Can Ténordate interact with cold or flu medicines?

A: Cold and flu remedies often contain ingredients that can interact with Ténordate. This includes common ingredients like Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and official information suggests potential interactions with other ingredients like decongestants due to their effects on blood pressure.


Q: Does Ténordate have a risk of affecting liver function?

A: Official documents indicate that caution is required in patients with pre-existing hepatic (liver) disease. Additionally, liver damage is sometimes cited as a serious adverse effect in clinical literature associated with drug components.


Q: Are there certain common side effects that usually go away after a few weeks?

A: Official labeling suggests that some effects, such as feeling dizzy or experiencing nausea, may be more pronounced when treatment begins and may lessen as the body adjusts.


Q: Can Ténordate be safely used by people with diabetes?

A: Use requires caution in patients with diabetes. Official warnings state that the beta-blocker component may mask symptoms of low blood sugar (hypoglycemia), such as a fast heart rate or hand tremors, making it harder for a patient to detect when their sugar levels drop.


Q: How long does the benefit of a single dose of Ténordate last?

A: The formulation is designed to provide sustained therapeutic benefit. Since the drug is officially prescribed for a once or twice daily regimen, a single dose is intended to maintain its therapeutic effect on the heart and blood vessels for approximately 12 to 24 hours.


Q: Is Ténordate the same as the active ingredient it contains?

A: No, Ténordate is a single fixed-dose combination product that contains two separate active ingredients: the beta-blocker Atenolol and the calcium channel blocker Nifedipine. It is not the same as either component alone.


Q: Why is it important to check blood pressure regularly while on Ténordate?

A: Regular monitoring is essential because the primary purpose of Ténordate is to lower blood pressure. Close monitoring ensures that the blood pressure is not dropping too rapidly or excessively, which can otherwise lead to adverse events like severe hypotension.


Q: Does Ténordate need to be taken at the exact same time every day?

A: Yes, to help ensure the medicine works consistently, official instructions advise taking the medicine at around the same time or times every day. This consistent timing helps maintain a steady level of the drug components in the body.

Advertisements

How should Ténordate be stored and disposed of?

Storage Requirements

Official labeling mandates that Ténordate tablets must be stored at controlled room temperature, typically maintained below 25 C. To preserve product integrity, the medicine must be protected from light and excess moisture.

Constraint Requirement
Temperature Controlled Room Temperature (Avoid excessive heat)
Container Kept in the original container, tightly closed
Environment Protect from light; do not freeze

The medicine must be stored out of the sight and reach of children in a secure location. The tablets must remain in their original, tightly closed container and should never be frozen or stored in damp environments.

Disposal Instructions

Unused or expired Ténordate must not be discarded into household garbage or flushed down the toilet, as instructed by regulatory guidelines. The correct procedure is to return the medication to a pharmacist or use an authorized drug take-back program for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ténordate found in:

A-Z Index: